CB1 receptor autoradiographic characterization of the individual differences in approach and avoidance motivation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Laricchiuta, Daniela ^a,b   Rojo, Maria Luisa ^c   Rodriguez Gaztelumendi, Antonio ^c   Ferlazzo, Fabio ^b   Petrosini, Laura ^a,b   Fowler, Christopher J ^c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; 3 (2 HYDROXY 4 (1,1 DIMETHYLHEPTYL)PHENYL) 4 (3 HYDROXYPROPYL)CYCLOHEXANOL; 3-(2-HYDROXY-4-(1,1-DIMETHYLHEPTYL)PHENYL)-4-(3-HYDROXYPROPYL)CYCLOHEXANOL; AMIDASE; CYCLOHEXANOL DERIVATIVE; FATTY-ACID AMIDE HYDROLASE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE);

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; APPROACH BEHAVIOR; ARTICLE; AUTORADIOGRAPHY; AVOIDANCE BEHAVIOR; BODY EQUILIBRIUM; BRAIN MAPPING; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; EMOTIONALITY; ENZYME ACTIVITY; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; INHIBITION (PSYCHOLOGY); MALE; MAZE TEST; MEDIAL AMYGDALA; MOTIVATION; MOUSE; NERVE CELL NETWORK; NONHUMAN; RECEPTOR DENSITY; ANIMAL; BRAIN; C57BL MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALIA; MUS;

AMIDOHYDROLASES; ANIMALS; AUTORADIOGRAPHY; AVOIDANCE LEARNING; BRAIN; CYCLOHEXANOLS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTIVATION; RECEPTOR, CANNABINOID, CB1;

EID: 84864400302     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042111     Document Type: Article

References (78)

1. Elliot AJ (2008) Approach and Avoidance Motivation. In: Handbook of approach and avoidance motivation. Elliot AJ, editor. New York: Psychology Press, Taylor & Francis Group. 3-14.
2. Hariri AR, ((2009)) The neurobiology of individual differences in complex behavioural traits. Annu Rev Neurosci 32:: 225--247.
3. Kelley AE, Schochet T, Landry CF, ((2004)) Risk taking and novelty seeking in adolescence: introduction to part I. Ann N Y Acad Sci 1021:: 27--32.
4. Cain CK, LeDoux JE (2008) Emotional Processing and Motivational: In Search of Brain Mechanisms. In: Handbook of approach and avoidance motivation. Elliot AJ, editor. New York: Psychology Press, Taylor & Francis Group. 17-34.
5. McDonald J, Schleifer L, Richards JB, de Wit H, ((2003)) Effects of THC on behavioural measures of impulsivity in humans. Neuropsychopharmacology 28:: 1356--1365.
6. Van Laere K, Goffin K, Bormans G, Casteels C, Mortelmans L, et al. ((2009)) Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament. Arch Gen Psychiatry 66:: 196--204.
7. Pattij T, Janssen MC, Schepers I, Gonzalez-Cuevas G, De Vries TJ, et al. ((2007)) Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behaviour in rats. Psychopharmacology (Berl) 193:: 85--96.
8. Lafenêtre P, Chaouloff F, Marsicano G, ((2009)) Bidirectional regulation of novelty-induced behavioural inhibition by the endocannabinoid system. Neuropharmacology 57:: 715--721.
9. Häring M, Kaiser N, Monory K, Lutz B, ((2011)) Circuit Specific Functions of CannabinoidCB1 Receptor in the Balance of Investigatory Drive and Exploration. PLoS ONE 6:: e26617.
10. Laricchiuta D, Rossi S, Musella A, De Chiara V, Cutuli D, et al. ((2012)) Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission. PLoS ONE 7:: e33260.
11. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O, ((2002)) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 159:: 379--387.
12. Witkin JM, Tzavara ET, Nomikos GG, ((2005)) A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav Pharmacol 16:: 315--331.
13. Lutz B, ((2007)) The endocannabinoid system and extinction learning. Mol Neurobiol 36:: 92--101.
14. Patel S, Hillard CJ, ((2008)) Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 27:: 2821--2829.
15. Lutz B, ((2009)) Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 9:: 46--52.
16. Maldonado R, Valverde O, Berrendero F, ((2006)) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29:: 225--232.
17. Marsicano G, Lutz B, ((2006)) Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest 29:: 27--46.
18. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M, ((2009)) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89:: 309--380.
19. Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, et al. ((2003)) Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 27:: 289--301.
20. Mahler SV, Smith KS, Berridge KC, ((2007)) Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 32:: 2267--2278.
21. Cabral GA, Griffin-Thomas L, ((2009)) Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med 11:: e3.
22. Fowler CJ, Rojo ML, Rodriguez-Gaztelumendi A, ((2010)) Modulation of the endocannabinoid system: neuroprotection or neurotoxicity? Exp Neurol 224:: 37--47.
23. Freund TF, Katona I, Piomelli D, ((2003)) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:: 1017--1066.
24. Piomelli D, ((2003)) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:: 873--884.
25. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R, ((2006)) The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27:: 73--100.
26. Matias I, Di Marzo V, ((2007)) Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 18:: 27--37.
27. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, et al. ((1990)) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:: 1932--1936.
28. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, et al. ((1999)) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19:: 4544--4558.
29. Marsicano G, Lutz B, ((1999)) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11:: 4213--4225.
30. Robson P, ((2005)) Human studies of cannabinoids and medicinal cannabis. Handb Exp Pharmacol 168:: 719--756.
31. Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, et al. ((2007)) Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology (Berl) 192:: 61--70.
32. Moreira FA, Kaiser N, Monory K, Lutz B, ((2008)) Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54:: 141--150.
33. Arnett JJ, ((1999)) Adolescent storm and stress, reconsidered. Am Psychol 54:: 317--326.
34. Spear LP, ((2002)) The adolescent brain and the college drinker: biological basis of propensity to use and misuse alcohol. J Stud Alcohol Suppl pp. 71--81.
35. Adriani W, Laviola G, ((2004)) Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol 15:: 341--352.
36. Slawecki CJ, ((2005)) Comparison of anxiety-like behaviour in adolescent and adult Sprague-Dawley rats. Behav Neurosci 119:: 1477--1483.
37. Hefner K, Holmes A, ((2007)) Ontogeny of fear-, anxiety- and depression-related behaviour across adolescence in C57BL/6J mice. Behav Brain Res 176:: 210--215.
38. Good RL, Radcliffe RA, ((2011)) Methamphetamine-induced locomotor changes are dependent on age, dose and genotype. Pharmacol Biochem Behav 98:: 101--111.
39. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, et al. ((2000)) Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology 25:: 479--496.
40. Linfoot I, Gray M, Bingham B, Williamson M, Pinel JP, et al. ((2009)) Naturally occurring variations in defensive burying behaviour are associated with differences in vasopressin, oxytocin, and androgen receptors in the male rat. Prog Neuropsychopharmacol Biol Psychiatry 33:: 1129--1140.
41. Robbins TW, Everitt BJ, ((1996)) Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6:: 228--236.
42. Meyer B, Johnson SL, Carver CS, ((1999)) Exploring behavioural activation and inhibition sensitivities among college students at risk for bipolar spectrum symptomatology. J Psychopathol Behav Assess 21:: 275--292.
43. Muris P, Merckelbach H, Schmidt H, Gadet BB, Bogie N, ((2001)) Anxiety and depression as correlates of self-reported behavioural inhibition in normal adolescents. Behav Res Ther 39:: 1051--1061.
44. Kasch KL, Rottenberg J, Arnow BA, Gotlib IH, ((2002)) Behavioural activation and inhibition systems and the severity and course of depression. J Abnorm Psychol 111:: 589--597.
45. Mitchell JT, Nelson-Gray RO, ((2006)) Attention-deficit/hyperactivity disorder symptoms in adults: relationship to Gray's behavioural approach system. Pers Individ Differ 40:: 749--760.
46. Chambers RA, Potenza MN, ((2003)) Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud 19:: 53--84.
47. Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP, et al. ((2003)) The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev 27:: 33--44.
48. Wallace JM Jr, Bachman JG, O'Malley PM, Schulenberg JE, Cooper SM, et al. ((2003)) Gender and ethnic differences in smoking, drinking and illicit drug use among American 8th, 10th and 12th grade students, 1976-2000. Addiction 98:: 225--234.
49. Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernández-Ruiz JJ, ((1999)) Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33:: 181--191.
50. Al-Hayani A, Davies SN, ((2000)) Cannabinoid receptor mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated. Br J Pharmacol 131:: 663--665.
51. Moesgaard B, Petersen G, Jaroszewski JW, Hansen HS, ((2000)) Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study. J Lipid Res 41:: 985--990.
52. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, et al. ((2007)) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:: 391--404.
53. Roberts BW, Caspi A, Moffitt TE, ((2001)) The kids are alright: Growth and stability in personality from adolescence to adulthood. Pers Soc Psychol 81:: 670--683.
54. Maccarrone M, Finazzi-Agrò A, ((2002)) Endocannabinoids and their actions. Vitam Horm 65:: 225--255.
55. Gifford AN, Bruneus M, Gatley SJ, Lan R, Makriyannis A, et al. ((1999)) Large receptor reserve for cannabinoid actions in the central nervous system. J Pharmacol Exp Ther 288:: 478--83.
56. Breivogel CS, Childers SR, ((2000)) Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J Pharmacol Exp Ther 295:: 328--336.
57. Brand T, Spanagel R, Schneider M, ((2012)) Decreased reward sensitivity in rats from the Fischer 344 strain compared to Wistar rats is paralleled by differences in endocannabinoid signaling. PLoS One 7:: e31169.
58. Gjedde A, Kumakura Y, Cumming P, Linnet J, Møller A, ((2010)) Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proc Natl Acad Sci U S A 107:: 3870--3875.
59. Pape HC, Pare D, ((2010)) Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev 90:: 419--463.
60. Ono T, Nishijo H, Uwano T, ((1995)) Amygdala role in conditioned associative learning. Prog Neurobiol 46:: 401--422.
61. McGaugh JL, ((2004)) The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27:: 1--28.
62. LaBar KS, Cabeza R, ((2006)) Cognitive neuroscience of emotional memory. Nat Rev Neurosci 7:: 54--64.
63. Schwartz CE, Wright CI, Shin LM, Kagan J, Rauch SL, ((2003)) Inhibited and uninhibited infants "grown up": adult amygdalar response to novelty. Science 300:: 1952--1953.
64. Weierich MR, Wright CI, Negreira A, Dickerson BC, Barrett LF, ((2010)) Novelty as a dimension in the affective brain. Neuroimage 49:: 2871--2878.
65. Davis M, Whalen PJ, ((2001)) The amygdala: vigilance and emotion. Mol Psychiatry 6:: 13--34.
66. LeDoux JE, ((2000)) Emotion circuits in the brain. Annu Rev Neurosci 23:: 155--184.
67. Royer S, Martina M, Paré D, ((1999)) An inhibitory interface gates impulse trafic between the input and output stations of the amygdala. J Neurosci 19:: 10575--10583.
68. Jamshidi N, Taylor DA, ((2001)) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134:: 1151--1154.
69. Ikemoto S, Panksepp J, ((1999)) The role of nucleus accumbens dopamine in motivated behaviour: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 31:: 6--41.
70. Wise RA, ((2006)) Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361:: 1149--1158.
71. Bassareo V, De Luca MA, Di Chiara G, ((2002)) Differential Expression of Motivational Stimulus Properties by Dopamine in Nucleus Accumbens Shell versus Core and Prefrontal Cortex. J Neurosci 22:: 4709--4719.
72. Glass M, Dragunow M, Faull RL, ((1999)) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:: 299--318.
73. Mato S, Pazos A, ((2004)) Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology 46:: 716--726.
74. Sim LJ, Hampson RE, Deadwyler SA, Childers SR, ((1996)) Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 16:: 8057--8066.
75. Rodríguez-Gaztelumendi A, Rojo ML, Pazos A, Díaz A, ((2009)) Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine. J Neurochem 108:: 1423--1433.
76. Boldrup L, Wilson SJ, Barbier AJ, Fowler CJ, ((2004)) A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. J Biochem Biophys Methods 60:: 171--177.
77. Efron B, Tibshirani RJ, ((1993)) An introduction to the bootstrap. London: Chapman & Hall.
78. Di Nocera F, Ferlazzo F, ((2000)) Resampling approach to statistical inference: Bootstrapping from event related potentials data. Behav Res Methods Instrum Comput 32:: 111--119.